Annual CFO
-$7.09 M
+$1.09 M+13.33%
31 December 2023
Summary:
Titan Pharmaceuticals annual cash flow from operations is currently -$7.09 million, with the most recent change of +$1.09 million (+13.33%) on 31 December 2023. During the last 3 years, it has risen by +$10.11 million (+58.77%). TTNP annual CFO is now -202.78% below its all-time high of $6.90 million, reached on 31 December 1997.TTNP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$2.07 M
-$1.46 M-237.36%
30 June 2024
Summary:
Titan Pharmaceuticals quarterly cash flow from operations is currently -$2.07 million, with the most recent change of -$1.46 million (-237.36%) on 30 June 2024. Over the past year, it has dropped by -$233.00 thousand (-12.70%). TTNP quarterly CFO is now -115.31% below its all-time high of $13.51 million, reached on 30 June 2016.TTNP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$6.76 M
-$956.00 K-16.47%
30 June 2024
Summary:
Titan Pharmaceuticals TTM cash flow from operations is currently -$6.76 million, with the most recent change of -$956.00 thousand (-16.47%) on 30 June 2024. Over the past year, it has dropped by -$337.00 thousand (-5.25%). TTNP TTM CFO is now -185.05% below its all-time high of $7.95 million, reached on 30 June 2016.TTNP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.3% | -12.7% | -5.3% |
| 3 y3 years | +58.8% | +8.6% | +40.6% |
| 5 y5 years | +15.9% | +37.8% | +55.2% |
TTNP Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +58.8% | -237.4% | +30.2% | -16.5% | +40.6% |
| 5 y | 5 years | at high | +58.8% | -237.4% | +60.3% | -16.5% | +60.7% |
| alltime | all time | -202.8% | +75.8% | -115.3% | +74.5% | -185.1% | +76.9% |
Titan Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$2.07 M(+237.4%) | -$6.76 M(+16.5%) |
| Mar 2024 | - | -$613.00 K(-72.7%) | -$5.81 M(-18.1%) |
| Dec 2023 | -$7.09 M(-13.3%) | -$2.25 M(+22.4%) | -$7.09 M(+10.4%) |
| Sept 2023 | - | -$1.83 M(+65.0%) | -$6.42 M(-0.6%) |
| June 2023 | - | -$1.11 M(-41.4%) | -$6.46 M(-9.2%) |
| Mar 2023 | - | -$1.90 M(+20.3%) | -$7.12 M(-13.0%) |
| Dec 2022 | -$8.18 M(+3.6%) | -$1.58 M(-15.7%) | -$8.18 M(+6.5%) |
| Sept 2022 | - | -$1.87 M(+6.0%) | -$7.68 M(-4.8%) |
| June 2022 | - | -$1.77 M(-40.4%) | -$8.07 M(-2.0%) |
| Mar 2022 | - | -$2.96 M(+174.2%) | -$8.24 M(+4.3%) |
| Dec 2021 | -$7.90 M(-54.1%) | -$1.08 M(-52.2%) | -$7.90 M(-30.6%) |
| Sept 2021 | - | -$2.26 M(+17.1%) | -$11.38 M(-9.4%) |
| June 2021 | - | -$1.93 M(-26.4%) | -$12.56 M(-14.0%) |
| Mar 2021 | - | -$2.63 M(-42.4%) | -$14.62 M(-15.0%) |
| Dec 2020 | -$17.20 M(+11.4%) | -$4.56 M(+32.3%) | -$17.20 M(+5.5%) |
| Sept 2020 | - | -$3.45 M(-13.5%) | -$16.30 M(+0.8%) |
| June 2020 | - | -$3.98 M(-23.6%) | -$16.18 M(-1.0%) |
| Mar 2020 | - | -$5.21 M(+42.3%) | -$16.35 M(+5.9%) |
| Dec 2019 | -$15.45 M(+83.2%) | -$3.66 M(+10.2%) | -$15.45 M(+2.4%) |
| Sept 2019 | - | -$3.33 M(-19.9%) | -$15.09 M(+7.5%) |
| June 2019 | - | -$4.15 M(-3.7%) | -$14.03 M(+19.5%) |
| Mar 2019 | - | -$4.31 M(+30.2%) | -$11.74 M(+39.2%) |
| Dec 2018 | -$8.43 M(-33.5%) | -$3.31 M(+45.9%) | -$8.43 M(-2.2%) |
| Sept 2018 | - | -$2.27 M(+22.2%) | -$8.63 M(-12.9%) |
| June 2018 | - | -$1.86 M(+85.8%) | -$9.90 M(-6.3%) |
| Mar 2018 | - | -$999.00 K(-71.5%) | -$10.57 M(-16.7%) |
| Dec 2017 | -$12.68 M(-301.4%) | -$3.50 M(-1.2%) | -$12.68 M(+9.4%) |
| Sept 2017 | - | -$3.54 M(+40.7%) | -$11.58 M(+7.2%) |
| June 2017 | - | -$2.52 M(-19.0%) | -$10.81 M(-307.0%) |
| Mar 2017 | - | -$3.11 M(+29.2%) | $5.22 M(-17.0%) |
| Dec 2016 | $6.29 M(-184.3%) | -$2.41 M(-13.0%) | $6.29 M(-9.4%) |
| Sept 2016 | - | -$2.77 M(-120.5%) | $6.95 M(-12.7%) |
| June 2016 | - | $13.51 M(-762.8%) | $7.95 M(-206.3%) |
| Mar 2016 | - | -$2.04 M(+16.1%) | -$7.48 M(+0.2%) |
| Dec 2015 | -$7.47 M(+27.3%) | -$1.76 M(-0.3%) | -$7.47 M(+2.5%) |
| Sept 2015 | - | -$1.76 M(-8.3%) | -$7.28 M(+5.3%) |
| June 2015 | - | -$1.92 M(-5.1%) | -$6.92 M(+9.2%) |
| Mar 2015 | - | -$2.03 M(+28.9%) | -$6.33 M(+8.0%) |
| Dec 2014 | -$5.87 M(-40.1%) | -$1.57 M(+12.7%) | -$5.87 M(-8.3%) |
| Sept 2014 | - | -$1.40 M(+4.0%) | -$6.40 M(-10.9%) |
| June 2014 | - | -$1.34 M(-13.9%) | -$7.18 M(-25.6%) |
| Mar 2014 | - | -$1.56 M(-26.0%) | -$9.65 M(-1.5%) |
| Dec 2013 | -$9.80 M(-635.5%) | -$2.10 M(-3.4%) | -$9.80 M(-676.1%) |
| Sept 2013 | - | -$2.18 M(-42.8%) | $1.70 M(+13.2%) |
| June 2013 | - | -$3.81 M(+123.7%) | $1.50 M(-43.5%) |
| Mar 2013 | - | -$1.70 M(-118.1%) | $2.66 M(+45.2%) |
| Dec 2012 | $1.83 M(-112.6%) | $9.40 M(-495.3%) | $1.83 M(-118.8%) |
| Sept 2012 | - | -$2.38 M(-10.5%) | -$9.75 M(-8.8%) |
| June 2012 | - | -$2.66 M(+4.9%) | -$10.70 M(-28.2%) |
| Mar 2012 | - | -$2.53 M(+15.7%) | -$14.90 M(+2.9%) |
| Dec 2011 | -$14.48 M(+210.8%) | -$2.19 M(-34.1%) | -$14.48 M(-5.0%) |
| Sept 2011 | - | -$3.32 M(-51.6%) | -$15.24 M(+29.2%) |
| June 2011 | - | -$6.86 M(+225.4%) | -$11.79 M(+130.6%) |
| Mar 2011 | - | -$2.11 M(-28.5%) | -$5.11 M(+9.8%) |
| Dec 2010 | -$4.66 M | -$2.95 M(-2404.7%) | -$4.66 M(+73.1%) |
| Sept 2010 | - | $128.00 K(-170.3%) | -$2.69 M(-33.0%) |
| June 2010 | - | -$182.00 K(-89.0%) | -$4.01 M(-26.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | -$1.65 M(+68.2%) | -$5.48 M(+1.4%) |
| Dec 2009 | -$5.41 M(-64.4%) | -$983.00 K(-17.8%) | -$5.41 M(+22.2%) |
| Sept 2009 | - | -$1.20 M(-27.6%) | -$4.42 M(-52.3%) |
| June 2009 | - | -$1.65 M(+4.7%) | -$9.28 M(-32.8%) |
| Mar 2009 | - | -$1.58 M(-74.0%) | -$13.82 M(-37.6%) |
| Sept 2008 | - | -$6.05 M(-2.2%) | -$22.14 M(+9.3%) |
| June 2008 | - | -$6.19 M(+11.3%) | -$20.25 M(+15.6%) |
| Mar 2008 | - | -$5.56 M(+28.4%) | -$17.52 M(+15.3%) |
| Dec 2007 | -$15.19 M(+12.5%) | -$4.33 M(+3.9%) | -$15.19 M(+4.5%) |
| Sept 2007 | - | -$4.17 M(+20.7%) | -$14.53 M(+8.9%) |
| June 2007 | - | -$3.45 M(+6.7%) | -$13.34 M(+9.7%) |
| Mar 2007 | - | -$3.23 M(-12.0%) | -$12.16 M(-9.9%) |
| Dec 2006 | -$13.50 M(-41.1%) | -$3.68 M(+23.6%) | -$13.50 M(-11.6%) |
| Sept 2006 | - | -$2.98 M(+30.7%) | -$15.27 M(-14.0%) |
| June 2006 | - | -$2.28 M(-50.2%) | -$17.75 M(-20.3%) |
| Mar 2006 | - | -$4.57 M(-16.1%) | -$22.26 M(-2.9%) |
| Dec 2005 | -$22.92 M(-4.1%) | -$5.45 M(-0.1%) | -$22.92 M(-5.3%) |
| Sept 2005 | - | -$5.45 M(-19.7%) | -$24.20 M(+1.6%) |
| June 2005 | - | -$6.79 M(+29.8%) | -$23.83 M(-0.6%) |
| Mar 2005 | - | -$5.23 M(-22.3%) | -$23.96 M(+0.2%) |
| Dec 2004 | -$23.91 M(-9.6%) | -$6.73 M(+32.6%) | -$23.91 M(-1.6%) |
| Sept 2004 | - | -$5.08 M(-26.7%) | -$24.29 M(-3.2%) |
| June 2004 | - | -$6.93 M(+33.8%) | -$25.11 M(+2.7%) |
| Mar 2004 | - | -$5.18 M(-27.2%) | -$24.45 M(-7.5%) |
| Dec 2003 | -$26.44 M(-9.7%) | -$7.11 M(+20.7%) | -$26.44 M(-3.6%) |
| Sept 2003 | - | -$5.89 M(-6.0%) | -$27.42 M(-5.7%) |
| June 2003 | - | -$6.27 M(-12.4%) | -$29.07 M(+1.4%) |
| Mar 2003 | - | -$7.16 M(-11.6%) | -$28.68 M(-2.1%) |
| Dec 2002 | -$29.29 M(+113.2%) | -$8.10 M(+7.3%) | -$29.29 M(+22.6%) |
| Sept 2002 | - | -$7.54 M(+28.3%) | -$23.90 M(+12.0%) |
| June 2002 | - | -$5.88 M(-24.3%) | -$21.34 M(+27.9%) |
| Mar 2002 | - | -$7.77 M(+187.6%) | -$16.69 M(+21.5%) |
| Dec 2001 | -$13.74 M(+4.4%) | -$2.70 M(-45.9%) | -$13.74 M(-6.9%) |
| Sept 2001 | - | -$4.99 M(+307.0%) | -$14.76 M(+11.5%) |
| June 2001 | - | -$1.23 M(-74.6%) | -$13.24 M(-5.0%) |
| Mar 2001 | - | -$4.82 M(+29.6%) | -$13.93 M(+5.8%) |
| Dec 2000 | -$13.16 M(+20.8%) | -$3.72 M(+7.2%) | -$13.16 M(+10.2%) |
| Sept 2000 | - | -$3.47 M(+81.0%) | -$11.94 M(+5.9%) |
| June 2000 | - | -$1.92 M(-52.7%) | -$11.27 M(-8.8%) |
| Mar 2000 | - | -$4.06 M(+62.3%) | -$12.36 M(+13.4%) |
| Dec 1999 | -$10.90 M(-16.8%) | -$2.50 M(-10.7%) | -$10.90 M(-1.8%) |
| Sept 1999 | - | -$2.80 M(-6.7%) | -$11.10 M(+1.8%) |
| June 1999 | - | -$3.00 M(+15.4%) | -$10.90 M(+5.8%) |
| Mar 1999 | - | -$2.60 M(-3.7%) | -$10.30 M(-21.4%) |
| Dec 1998 | -$13.10 M(-289.9%) | -$2.70 M(+3.8%) | -$13.10 M(-645.8%) |
| Sept 1998 | - | -$2.60 M(+8.3%) | $2.40 M(-366.7%) |
| June 1998 | - | -$2.40 M(-55.6%) | -$900.00 K(-113.2%) |
| Mar 1998 | - | -$5.40 M(-142.2%) | $6.80 M(-1.4%) |
| Dec 1997 | $6.90 M(-163.9%) | $12.80 M(-316.9%) | $6.90 M(-177.5%) |
| Sept 1997 | - | -$5.90 M(-211.3%) | -$8.90 M(+61.8%) |
| June 1997 | - | $5.30 M(-200.0%) | -$5.50 M(-59.6%) |
| Mar 1997 | - | -$5.30 M(+76.7%) | -$13.60 M(+25.9%) |
| Dec 1996 | -$10.80 M(+25.6%) | -$3.00 M(+20.0%) | -$10.80 M(+38.5%) |
| Sept 1996 | - | -$2.50 M(-10.7%) | -$7.80 M(+47.2%) |
| June 1996 | - | -$2.80 M(+12.0%) | -$5.30 M(+112.0%) |
| Mar 1996 | - | -$2.50 M | -$2.50 M |
| Dec 1995 | -$8.60 M | - | - |
FAQ
- What is Titan Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual CFO year-on-year change?
- What is Titan Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly CFO year-on-year change?
- What is Titan Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals TTM CFO year-on-year change?
What is Titan Pharmaceuticals annual cash flow from operations?
The current annual CFO of TTNP is -$7.09 M
What is the all time high annual CFO for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual cash flow from operations is $6.90 M
What is Titan Pharmaceuticals annual CFO year-on-year change?
Over the past year, TTNP annual cash flow from operations has changed by +$1.09 M (+13.33%)
What is Titan Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of TTNP is -$2.07 M
What is the all time high quarterly CFO for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly cash flow from operations is $13.51 M
What is Titan Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, TTNP quarterly cash flow from operations has changed by -$233.00 K (-12.70%)
What is Titan Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of TTNP is -$6.76 M
What is the all time high TTM CFO for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high TTM cash flow from operations is $7.95 M
What is Titan Pharmaceuticals TTM CFO year-on-year change?
Over the past year, TTNP TTM cash flow from operations has changed by -$337.00 K (-5.25%)